The Clinical Trials British Columbia Awards honour individuals and organizations who have made significant contributions to strengthening the BC clinical trials ecosystem. Award recipients exemplify excellence in leadership, advocacy for clinical trials, and outstanding service and support to advance clinical trials research and improve the health of people across British Columbia.
There are two award opportunities:
1. Leadership & Advocacy Award
This award honours outstanding leaders and advocates for clinical trials at the provincial and/or national level. Recipients are leaders who educate, mentor, advocate, or spearhead projects, programs, and strategies that benefit the clinical trials community.
2. Service & Support Award
This award recognizes the community-based, volunteer commitment of an individual, organization, company or agency to improve the clinical trials community.
Key dates
- Deadline for nominations is 11:59 p.m. PST on June 8, 2026.
- Award recipients will be announced in Fall 2026.
How to nominate
- View the awards eligibility and criteria in the Awards Guidance Document (PDF).
- Complete the Nomination Form (PDF).
- Attach the supporting documents.
- Submit your nomination package to the Clinical Trials British Columbia Awards Committee at ctbcawards@clinicaltrialsbc.ca by 11:59 p.m. PST on June 8, 2026.
After submitting your nomination package, you will receive a confirmation email that the nomination has been received. If the confirmation of receipt has not been received after 4 days, please get in touch with Jean Smart, Awards Committee Chair, jsmart@clinicaltrialsbc.ca.
Hear from last year’s recipients

Dr. Paul Anthony Keown
Director, Immune Sciences, Faculty of Medicine, University of British Columbia (UBC)
Research Excellence Cluster Lead, Precision Medicine in Transplantation, Faculty of Medicine, UBC
Professor, Faculty of Medicine, UBC Lead, Genome Canada Transplant Consortium
Practicing physician, Vancouver General Hospital President and CEO, Syreon
Principal Investigator, CanProspECT Program – Canadian Prospective Epitope Compatibility for Transplant

Stephania Manusha
Senior Director, Clinical Trials Strategy and Industry Relations, Vancouver Coastal Health Research Institute



